Eating Disorders Trial, Recruiting NCT06540703 Sponsor: University of California, San Diego Condition: Eating Disorders
Back to Eating Disorders

Eating Disorders Trial, Recruiting

NCT06540703
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For people with weight-recovered anorexia nervosa:

  • Adults between 18 and 45 years old, of any sex or ethnic background
  • People with a history of restricting-type anorexia nervosa (a form of anorexia focused on limiting food intake), as defined by standard psychiatric guidelines
  • People whose weight has recovered to a body mass index (BMI) above 17.5 for at least one month at the time of the study
  • People who still show elevated eating disorder-related thoughts or behaviours, as measured by two standard questionnaires (confirm with trial site)

For healthy volunteers (control group):

  • Adults between 18 and 45 years old, of any sex or ethnic background
  • People whose BMI has been in the normal range throughout their lifetime, according to standard public health guidelines

Who may not be able to join:

For people with weight-recovered anorexia nervosa:

  • People who are currently pregnant or breastfeeding (those who are sexually active would need to agree to use contraception)
  • People with a lifetime history of bipolar I disorder or psychosis
  • People who have used or been dependent on substances in the past three months
  • People with a psychotic illness, organic brain syndrome, dementia, or certain physical symptom disorders
  • People with a history of significant head injury
  • People with an indication of intellectual disability or autism spectrum disorder

For healthy volunteers (control group):

  • People with any lifetime history of a psychiatric illness, including any history of an eating disorder
  • People who are currently taking any medication
  • People who have a close family member (parent, sibling, or child) with an eating disorder

For everyone in both groups:

  • People with intellectual disability or a pervasive developmental disorder
  • People with an organic brain syndrome or dementia
  • People with a psychotic disorder or bipolar disorder
  • People with somatic symptom disorder or conversion disorder
  • People with a current alcohol or substance use disorder
  • People with a significant medical illness, including a history of seizures
  • People who are pregnant or breastfeeding at the time of the study
  • People with a history of traumatic brain injury
  • People with diabetes or other metabolic conditions that could be made worse by a ketogenic (very low carbohydrate) diet
  • People with metal objects inside or near the head that cannot be safely removed (excluding the mouth)
  • People with implanted nerve stimulators, lines inside the heart, or heart disease

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
2 October 2024
Est. completion
1 May 2029

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

[18F]fluorodeoxyglucose (FDG) uptake

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov